Minted: - / 5000

2536 Blonanserin
b75bee4518b104c51265fd7a3570acb086a5256ed4013ba907800576239b7b00

Properties

Background

Yellow
Bottle

Green
Cap

Blue
Syringe

Blue
Bubbles
No
Drops
No
Label
-

Chemistry

Formula
C23H30FN3
Carbon
23
Polarity
Neutral

Blonanserin, sold under the brand name Lonasen, is a relatively new atypical antipsychotic (approved by PMDA in January 2008) commercialized by Dainippon Sumitomo Pharma in Japan and Korea for the treatment of schizophrenia. Relative to many other antipsychotics, blonanserin has an improved tolerability profile, lacking side effects such as extrapyramidal symptoms, excessive sedation, or hypotension. As with many second-generation (atypical) antipsychotics it is significantly more efficacious in the treatment of the negative symptoms of schizophrenia compared to first-generation (typical) antipsychotics such as haloperidol.

From Wikipedia, the free encyclopedia. License: CC BY-SA.